Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed + Gemcitabine in Metastatic Breast Cancer
NCT00006007Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 2000
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pemetrexed in breast cancer, sponsored by Cancer and Leukemia Group B. Started Dec 2000; status: completed.
02
Drugs
pemetrexed
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00006007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006007.